Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 8 (2011), Issue 7 (July)

1. Age of first alcohol intoxication: association with risky drinking and other substance use at the age of 20.
   Swiss Med Wkly, 141: w13226. [Abstract] [Full-text]
2. Childhood sexual abuse and psychosis: data from a cross-sectional national psychiatric survey in England.
   Br J Psychiatry, 199: 29-37. [Abstract] [Full-text]
3. Occupational solvent exposure and brain function: an fMRI study.
   Environ Health Perspect, 119(7): 908-13. [Abstract] [Full-text]
4. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal.
   Drug Alcohol Depend, 117(1): 38-44. [Abstract] [Full-text]
5. Heterogeneity in the composition of marijuana seized in California.
   Drug Alcohol Depend, 117(1): 59-61. [Abstract] [Full-text]
6. Cigarette, marijuana, and alcohol use and prior drug treatment among newly homeless young adults in New York City: Relationship to a history of foster care.
   Drug Alcohol Depend, 117(1): 66-9. [Abstract] [Full-text]
7. Childhood predictors of first chance to use and use of cannabis by young adulthood.
   Drug Alcohol Depend, 117(1): 7-15. [Abstract] [Full-text]
8. Trajectories of marijuana use and psychological adjustment among urban African American and Puerto Rican women.
   Psychol Med, 41(8): 1775-83. [Abstract] [Full-text]
9. Marijuana use and tobacco smoking cessation among heavy alcohol drinkers.
   Drug Alcohol Depend. [Abstract] [Full-text]
10. The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress.
    Drug Alcohol Depend. [Abstract] [Full-text]
11. Instruments to detect alcohol and other drug misuse in the emergency department: a systematic review.
    Pediatrics, 128(1): e180-92. [Abstract] [Full-text]
12. Associations among sleep problems, learning difficulties and substance use in adolescence.
    J Adolesc, 34(4): 717-26. [Abstract] [Full-text]
13. Review article: cyclic vomiting syndrome in adults--rediscovering and redefining an old entity.
    Aliment Pharmacol Ther, 34(3): 263-73. [Abstract] [Full-text]
14. Racial/ethnic disparities in therapist effectiveness: a conceptualization and initial study of cultural competence.
    J Couns Psychol, 58(3): 290-8. [Abstract] [Full-text]
15. Drug-dependent inpatients reporting continuous absence of spontaneous drug craving for the main substance throughout detoxification treatment.
    Drug Alcohol Rev, 30(4): 403-10. [Abstract] [Full-text]
16. The Drinking Expectancy Questionnaire for Men who have Sex with Men (DEQ-MSM): a measure of substance-related beliefs.
    Drug Alcohol Rev, 30(4): 372-80. [Abstract] [Full-text]
17. Alcohol and cannabis abuse/dependence symptoms and life satisfaction in young adulthood.
    Drug Alcohol Rev. [Abstract] [Full-text]
18. Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.
    J Neurosci Res, 89(9): 1509-18. [Abstract] [Full-text]
19. Smoking, substance use, and mental health correlates in urban adolescent girls.
    J Community Health, 36(4): 552-8. [Abstract] [Full-text]
20. Cannabis and its derivatives: review of medical use.
    J Am Board Fam Med, 24(4): 452-62. [Abstract] [Full-text]
21. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.
    Mol Cancer Ther, 10(7): 1161-72. [Abstract] [Full-text]
22. Dimensions of adolescent psychopathology and relationships to suicide risk indicators.
    J Youth Adolesc, 40(8): 958-71. [Abstract] [Full-text]
23. Substance use and regional gray matter volume in individuals at high risk of psychosis.
    Eur Neuropsychopharmacol. [Abstract] [Full-text]
24. Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.
    Mol Neurobiol, 44(1): 102-10. [Abstract] [Full-text]
25. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.
    Anal Bioanal Chem, 401(2): 599-607. [Abstract] [Full-text]
26. Cannabis use in young people: the risk for schizophrenia.
    Neurosci Biobehav Rev, 35(8): 1779-87. [Abstract] [Full-text]
27. Reversible and regionally selective downregulation of brain cannabinoid CB(1) receptors in chronic daily cannabis smokers.
    Mol Psychiatry. [Abstract] [Full-text]
28. Marijuana-induced mania in a healthy adolescent: a case report.
    Gen Hosp Psychiatry. [Abstract] [Full-text]
29. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
    Br J Pharmacol, 163(7): 1344-64. [Abstract] [Full-text]
30. Hypothalamic-pituitary-adrenal axis reactivity to social stress and adolescent cannabis use: the TRAILS study.
    Addiction, 106(8): 1484-92. [Abstract] [Full-text]
31. Social gradient in initiation and transition to daily use of tobacco and cannabis during adolescence: a retrospective cohort study.
    Addiction, 106(8): 1520-31. [Abstract] [Full-text]
32. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
    Br J Pharmacol, 163(7): 1507-19. [Abstract] [Full-text]
33. The endocannabinoid system and cancer: therapeutic implication.
    Br J Pharmacol, 163(7): 1447-63. [Abstract] [Full-text]
34. Regulation of nausea and vomiting by cannabinoids.
    Br J Pharmacol, 163(7): 1411-22. [Abstract] [Full-text]
35. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
    Br J Pharmacol, 163(7): 1479-94. [Abstract] [Full-text]
36. The relationship between mental disorders and different types of crime.
    Crim Behav Ment Health. [Abstract] [Full-text]
37. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity.
    PLoS One, 6(7): e21917. [Abstract] [Full-text]
38. Epidemiology of psychoactive drug use amongst adolescents in metropolitan Lagos, Nigeria.
    Eur Child Adolesc Psychiatry, 20(7): 351-9. [Abstract] [Full-text]
39. How do Australian news media depict illicit drug issues? An analysis of print media reporting across and between illicit drugs, 2003-2008.
    Int J Drug Policy, 22(4): 285-91. [Abstract] [Full-text]
40. Protective associations of importance of religion and frequency of service attendance with depression risk, suicidal behaviours and substance use in adolescents in Nova Scotia, Canada.
    J Affect Disord, 132(3): 389-95. [Abstract] [Full-text]
41. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Life Sci, 89(5): 165-70. [Abstract] [Full-text]
42. Gender effects on amygdala morphometry in adolescent marijuana users.
    Behav Brain Res, 224(1): 128-34. [Abstract] [Full-text]
43. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine.
    J Psychopharmacol. [Abstract] [Full-text]
44. Adolescent exposure to cannabis as a risk factor for psychiatric disorders.
    J Psychopharmacol. [Abstract] [Full-text]
45. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.
    Schizophr Res, 130(1): 222-7. [Abstract] [Full-text]
46. Cannabis with high cannabidiol content is associated with fewer psychotic experiences.
    Schizophr Res, 130(1): 216-21. [Abstract] [Full-text]
47. Psychobiological responses to unpleasant emotions in cannabis users.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
48. Endocannabinoid CB1 receptors modulate visual output from the thalamus.
    Psychopharmacology (Berl). [Abstract] [Full-text]
49. Cannabis and progression to other substance use in young adults: findings from a 13-year prospective population-based study.
    J Epidemiol Community Health. [Abstract] [Full-text]
50. A Mixture IRT Analysis of Risky Youth Behavior.
    Front Psychol, 2: 98. [Abstract] [Full-text]
51. Acute heroin intoxication in a baby chronically exposed to cocaine and heroin: a case report.
    J Med Case Reports, 5(1): 288. [Abstract] [Full-text]
52. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.
    Psychopharmacology (Berl), 216(4): 545-56. [Abstract] [Full-text]
53. The emergence and analysis of synthetic cannabinoids.
    Drug Test Anal, 3(7): 466-78. [Abstract] [Full-text]
54. HIV-related risk behaviors among kathoey (male-to-female transgender) sex workers in Bangkok, Thailand.
    AIDS Care. [Abstract] [Full-text]
55. Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment.
    Water Res, 45(15): 4437-48. [Abstract] [Full-text]
56. Medial temporal structures and memory functions in adolescents with heavy cannabis use.
    J Psychiatr Res, 45(8): 1055-66. [Abstract] [Full-text]
57. The longitudinal relationships between rural adolescents' prosocial behaviors and young adult substance use.
    J Youth Adolesc, 40(9): 1192-202. [Abstract] [Full-text]
58. Patterns of alcohol and drug use among depressed older adults seeking outpatient psychiatric services.
    Am J Geriatr Psychiatry, 19(8): 695-703. [Abstract] [Full-text]
59. Young cannabis users in residential treatment: as distressed as other clients.
    Subst Use Misuse, 46(10): 1335-45. [Abstract] [Full-text]
60. Religiosity as a protective factor against substance use among Hungarian high school students.
    Subst Use Misuse, 46(10): 1346-57. [Abstract] [Full-text]
61. Motivational interviewing integrated with social network counseling for female adolescents: a randomized pilot study in urban primary care.
    J Subst Abuse Treat, 41(2): 148-55. [Abstract] [Full-text]
62. Oral health of substance-dependent individuals: impact of specific substances.
    J Subst Abuse Treat, 41(2): 179-85. [Abstract] [Full-text]
63. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
    Psychopharmacology (Berl). [Abstract] [Full-text]
64. Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls.
    Hum Psychopharmacol. [Abstract] [Full-text]
65. The Insults of Recreational Drug Abuse on Male Fertility.
    J Androl. [Abstract] [Full-text]
66. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
    Psychol Med. [Abstract] [Full-text]
67. CB1 - Cannabinoid Receptor Antagonist Effects on Cortisol in Cannabis-Dependent Men.
    Am J Drug Alcohol Abuse. [Abstract] [Full-text]
68. European youth care sites serve different populations of adolescents with cannabis use disorder. Baseline and referral data from the INCANT trial.
    BMC Psychiatry, 11: 110. [Abstract] [Full-text]
69. College students and use of K2: an emerging drug of abuse in young persons.
    Subst Abuse Treat Prev Policy, 6: 16. [Abstract] [Full-text]
70. Correlation between driving-related skill and alcohol use in young-adults from six European countries: the TEN-D by Night Project.
    BMC Public Health, 11: 526. [Abstract] [Full-text]
71. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Clin Chem, 57(8): 1127-36. [Abstract] [Full-text]
72. Clinical correlates of maltreatment and traumatic experiences in childhood and adolescence among predominantly African American, socially disadvantaged, hospitalized, first-episode psychosis patients.
    Psychiatry Res, 188(3): 343-9. [Abstract] [Full-text]
73. Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.
    Psychiatry Res, 188(3): 310-4. [Abstract] [Full-text]
74. HIV-Testing Practices and a History of Substance Use among Women Living in Public Housing in Puerto Rico.
    J Int Assoc Physicians AIDS Care (Chic), 10(4): 260-5. [Abstract] [Full-text]

© 2004-2013 Marijuana Research Today. All Rights Reserved.